Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 61-70 of 83 for Kidney cancer

Edit search filters
  1. A Study to Evaluate Software On Cross-sectional Imaging Evaluation of Microwave-ablated Liver Tumors

    Rochester, MN

  2. Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary Cancer and Changes in Gut Microbiome

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. A Study of Contribution of 3D Models in Resection of Renal Cell Cancer

    Rochester, MN

  4. A Databank Study of Molecular Circulatory Biomarkers in Non-localized Renal and Testicular Cancer Patients

    Rochester, MN, Jacksonville, FL

  5. Impact of Surgical Removal or Reduction Procedures on Markers of Immune Function in Adult Patients with Renal and Bladder Tumors and Pediatric Patients with Genitourinary Tumors

    Rochester, MN, Rochester, MN

  6. A Study to Evaluate Immune Markers in Patients with Renal Cell Cancer

    Rochester, MN

  7. A Study of Predictors of Renal Insufficiency Following Orthotopic Liver Transplantation

    Rochester, MN

  8. Treating Highly Sensitized Patients on the Kidney Transplant Waiting List by Depleting Their B-cells Using Chimeric Antigen Receptor T Cells (CAR-T)

    Jacksonville, FL

  9. Outcomes Database to prospectivelY aSSEss the Changing TherapY Landscape in Renal Cell Carcinoma (ODYSSEY RCC)

    Rochester, MN

  10. Renal Mass Registry

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer